glp-1 options for type 2 diabetes and obesity 2025 What is the pipeline future medications for obesity? GLP-1-based therapies for diabetes, obesity

If your A1C is really high, the injection might give you a better chance of getting to target

[PubMed] 102.Wadden T.A., Tsai A.G., Tronieri J.S

If experiencing these despite efforts, contact your doctor same day

But the fact that patients must take these drugs into perpetuity to maintain their effects makes the potential cost base quite large, especially given the large size of the total addressable market

Both hormones matter, but GLP-1 is likely the primary driver with GIP providing substantial enhancement

More recently, a Because tirzepatide is both a Still, its important to keep in mind that there are limitations to these studies, and more long-term research is needed before determining that one medication is more effective than another